ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Imvax Appoints Sean Hemingway Chief Operating Officer
April 09, 2021Imvax, Inc., a developer of immunotherapy for Glioblastoma (GBM) and other cancers, has appointed Sean Hemingway as Chief Operating Officer. -
IGV-001 demonstrates success against glioblastoma in Phase Ib trial
January 28, 2021Imvax’s Phase Ib clinical trial of IGV-001 for patients with newly diagnosed glioblastoma has shown positive results. -
Imvax Appoints Wendy DiCicco as New Board Member
September 17, 2020Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with malignant glioblastomas (GBM) and other solid tumors with significant unmet medical needs, announced the appointment of Wendy DiCicco to its board of ... -
Imvax Appoints Chief Scientific Officer
April 24, 2020Mark Exley brings experience in the regulation of the immune system to treat cancer and other diseases.
Pharma Sources Insight January 2025
